Mustang Bio Files Definitive Proxy Statement

TL;DR

Mustang Bio (MBIO) filed its proxy statement for the 12/26 meeting. Get ready to vote!

AI Summary

Mustang Bio, Inc. filed its definitive proxy statement on December 6, 2024, for its annual meeting on December 26, 2024. The filing, under SEC Act of 1934, concerns the company's governance and shareholder matters. Mustang Bio, Inc. is a pharmaceutical preparations company based in Worcester, MA.

Why It Matters

This filing provides shareholders with crucial information regarding the company's upcoming meeting, allowing them to make informed decisions on corporate governance and voting matters.

Risk Assessment

Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new financial performance data or significant operational changes.

Key Players & Entities

• MUSTANG BIO, INC. (company) — Registrant
• 0001680048 (company) — Central Index Key
• 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
• 473828760 (company) — IRS Number
• DE (company) — State of Incorporation
• 1231 (company) — Fiscal Year End
• 001-38191 (company) — SEC File Number
• 241533044 (company) — Film Number
• 377 PLANTATION STREET (company) — Business Address Street 1
• WORCESTER (company) — Business Address City

FAQ

Filing Documents

• tmb-20241226xdef14a.htm (DEF 14A) — 657KB
• tmb-20241226xdef14a_a001.jpg (GRAPHIC) — 9KB
• tmb-20241226xdef14a_a005.jpg (GRAPHIC) — 44KB
• tmb-20241226xdef14a_bg001.jpg (GRAPHIC) — 111KB
• tmb-20241226xdef14a_bg002.jpg (GRAPHIC) — 91KB
• 0001558370-24-016070.txt ( ) — 1002KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 17 SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS 22 DIRECTOR COMPENSATION 22 Director Compensation Program 22 Director Compensation Table 23 DELINQUENT SECTION 16(a) REPORTS 23 RELATED-PERSON TRANSACTIONS 24 STOCK OWNERSHIP OF OUR DIRECTORS, EXECUTIVE OFFICERS, AND 5% BENEFICIAL OWNERS 27 PROPOSAL ONE: ELECTION OF DIRECTORS; NOMINEES 29 PROPOSAL TWO: RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 30 ADDITIONAL INFORMATION 31 Householding of Annual Meeting Materials 31 Stockholder Proposals for Our 2024 Annual Meeting 31 Other Matters 31 Solicitation of Proxies 31 Incorporation of Information by Reference 31 i Table of Contents QUESTIONS AND ANSWERS Q: When is the Annual Meeting? A. The Annual Meeting will be held at 9:00 a.m., Eastern Time, on December 26, 2024 . Q: Where will the Annual Meeting be held? A. The Annual Meeting will be held virtually by means of a live webcast, as further described herein, which can be accessed at www.virtualshareholdermeeting.com/MBIO2024 when you enter your 16-digit control number included with your proxy card. Q: What is the purpose of the Annual Meeting? A. At the Annual Meeting, our stockholders will act upon the matters outlined in the Notice of Annual Meeting of Stockholders accompanying this proxy statement, including (i) the election of seven directors for a term of one year, (ii) the ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2024, and (iii) the transaction of any other business that may properly come before the Annual Meeting or any adjournment thereof. Q. Who is entitled to vote at our Annual Meeting? A. Only stockholders of record at the close of business on, December 4 , 2024 , which we refer to as the Record Date, are entitled to receive notice of the Annual Meeting and t

View Full Filing

View this DEF 14A filing on SEC EDGAR